This article describes how to improve the regulatory journey from classification to market clearance for sponsors of medical device combination products. More chronically ill patients are relying on ...

Wu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations ...